title: [Application of endolaser in vitrectomy for retinal vascular disease].
abstract: OBJECTIVE
  To discuss the usage and effectiveness of endolaser in vitrectomy for retinal vascular disease.
  
  
  METHODS
  Twenty-four cases (28 eyes) of vitrectomy for retinal vascular disease were treated with endolaser. The methods of endolaser: 21 eyes were treated with panretinal scatter therapy; 2 eyes with endolaser ring-intercepting around retinal and sealing retinal breaks; 5 eye with focal therapy.
  
  
  RESULTS
  After follow-up for 1-24 months (mean 9 months), retinal hemorrhage recurred in 3 eyes; the other 25 eyes, retinas were totally reattached, retinal breaks were sealed, and vision had considerable recovery, no hemorrhage. The ratio of recovery is up to 89.2%.
  
  
  CONCLUSIONS
  Endolaser is an important adjuvant in vitreous operation nowadays and an effective procedure in vitrectomy for the cases of retinal hemorrhage.
authors.affiliation: Guangzhou Railway Central Hospital, Guangzhou 510080, China.
authors.forename: Jing
authors.initials: J
authors.lastname: Zang
authors.forename: Binbing
authors.initials: B
authors.lastname: Zhou
authors.forename: Jionglin
authors.initials: J
authors.lastname: Bao
authors.forename: Yudong
authors.initials: Y
authors.lastname: Zhu
authors.forename: Wenxiong
authors.initials: W
authors.lastname: Lin
authors.forename: Qing
authors.initials: Q
authors.lastname: Li
authors.forename: Qingning
authors.initials: Q
authors.lastname: Bian
authors.forename: Shaochong
authors.initials: S
authors.lastname: Zhang
authors.forename: Rulong
authors.initials: R
authors.lastname: Gao
authors.forename: Lirong
authors.initials: L
authors.lastname: He
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003930:Diabetic Retinopathy / Q000150:complications / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017075:Laser Coagulation; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases; D014792:Visual Acuity; D014821:Vitrectomy / Q000379:methods; D018630:Vitreoretinopathy, Proliferative / Q000150:complications / Q000601:surgery; D014823:Vitreous Hemorrhage / Q000150:complications / Q000601:surgery*